Highlights from ASH 2023 - Canadian Perspectives

2024-5-16 16:38

0 bullet chats

Unauthorized reproduction is prohibited

Presenting a recording of our webinar featuring Dr Jameel Abdulrehman, Dr Lana Castellucci, Dr Ali Amid and Dr Alfonso Iorio who each present their highlights of the December 2023 ASH meeting. In order of presentation: Dr Lana Castellucci presents summaries of the following: - Development and external validation of a Lymphoma-Specific Venous Thromboembolism Risk Assessment Model - Dynamic modelling for Cancer-Associated Venous Thromboembolism Dr Jameel Abdulrehman presents summaries of the following: • ASH anticoagulation for COVID guidelines • Meta-Analysis of National Level Genotyping Datasets to Determine the risk of Thrombosis in Double Heterozygous carriers of FVL and PT mutation... Dr Ali Amid presents summaries of the following: • Multicenter Study of a Risk Prediction Model for Critically Ill Children at High-Risk for Hospital-Acquired Venous Thromboembolism: Findings from the Children’s Hospital-Acquired Thrombosis (CHAT) Consortium • Once-Weekly Efanesoctocog Alfa Prophylaxis Provided High Sustained Factor VIII Activity Levels, Independent of Blood Group, in Children less than 12 Years of Age with Severe Hemophilia A Dr Alfonso Iorio present a summary of the following: • ASH 2023: Treatment of Venous Thromboembolism: Thrombophilia Testing

Comments 0

Please to post a comment~

ThrombosisCanada

DRLv2